Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Class B Common Stock
-
Shares outstanding
-
5.07M
-
Number of holders
-
509
-
Total 13F shares, excl. options
-
19M
-
Shares change
-
-534K
-
Total reported value, excl. options
-
$14.3B
-
Value change
-
-$402M
-
Put/Call ratio
-
2.37
-
Number of buys
-
229
-
Number of sells
-
-231
-
Price
-
$755.57
Significant Holders of BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) as of Q4 2021
579 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Class B Common Stock as of Q4 2021.
BIO-RAD LABORATORIES, INC. - Class B Common Stock (BIO) has 509 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (2.29M shares), FMR LLC (1.93M shares), BlackRock Inc. (1.77M shares), STATE STREET CORP (1.01M shares), ALLIANCEBERNSTEIN L.P. (586K shares), BROWN ADVISORY INC (539K shares), GEODE CAPITAL MANAGEMENT, LLC (427K shares), ACADIAN ASSET MANAGEMENT LLC (411K shares), BANK OF AMERICA CORP /DE/ (371K shares), and UBS ASSET MANAGEMENT AMERICAS INC (344K shares).
This table shows the top 509 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.